Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Sreenivasa Chandana, M.D., Ph.D., is one of six authors of “Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database,” which was published in Journal of Gastrointestinal Oncology. The article details survival trends amongst patients with small intestinal neuroendocrine tumors (SNETs), analyzing differences between patients who received surgery and did not receive surgery. The authors concluded that surgery significantly improved five-year survival rates in SNET patients. Read the study here.
Founded in 1979, CHCWM has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families. Thanks to the hard work of our growing staff, CHCWM has been named one of the Nation’s Best and Brightest Companies to Work For®. To learn more about CHCWM, visit chcwm.com.